Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

3106 PWToday Stories

PeriGen and Qualcomm Enter Strategic Licensing Agreement

28 Feb 18

PeriGen, the innovator of advanced perinatal systems, today announced a strategic reseller agreement with Qualcomm Incorporated (NASDAQ: QCOM), through its wholly owned subsidiary, Qualcomm Life, Inc. PeriGen's  FDA-cleared software uses artificial intelligence to provide labor and delivery clinicians with real time analysis of dynamic patient data that has contributed to improved clinical and medical malpractice outcomes.

The collaboration with PeriGen will allow Qualcomm Life to license and sell PeriWatch™ Vigilance™, a new early warning platform for obstetrics that automatically identifies patients whose conditions are worsening, facilitating more timely interventions. Vigilance augments currently installed fetal surveillance systems, providing a critical layer of patient safety without requiring a hospital to "rip and replace" current systems.  The "always on" software uses proprietary intelligent algorithms to analyze maternal vital signs, fetal heart rate, contractions and labor progress in real time, informing clinicians of emerging abnormalities. Specific thresholds and automated checklists can be configured according to each institution's preferences. PeriGen's solution will complement Qualcomm Life's Capsule™ product line to make care inside the hospital more intelligent by leveraging connected device and system data.

"As we grow our intelligent care product platform, we look to collaborate with companies that monitor patients and provide actionable insights for physicians and care teams," said James Mault, MD, FACS, senior vice president and chief medical officer of Qualcomm Life, Inc. "Our collaboration with PeriGen marks the first of Qualcomm Life's obstetric applications and we are thrilled to be able to work with PeriGen in an effort to garner more insights for patients."

"Clinicians are increasingly required to multitask, so the Vigilance early warning platform ensures that there is always a laser focus on spotting emerging issues and fostering communication and intervention before conditions worsen," said Matthew Sappern, CEO of PeriGen. "We are excited to collaborate with Qualcomm Life, a company with the same vision of leveraging medical device data to the benefit of patients and their care teams."

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.